advanced stage dementia and palliative care
play

Advanced Stage Dementia and Palliative Care 2013 NIH/ACL Alzheimers - PowerPoint PPT Presentation

Advanced Stage Dementia and Palliative Care 2013 NIH/ACL Alzheimers Webinar Series September 24, 2013 Welcome Ba sil E lda da h, MD, PhD Ac ting Chie f, Ge ria tric s Bra nc h Divisio n o f Ge ria tric s a nd Clinic a l Ge ro nto lo g y


  1. Advanced Stage Dementia and Palliative Care 2013 NIH/ACL Alzheimer’s Webinar Series September 24, 2013

  2. Welcome Ba sil E lda da h, MD, PhD Ac ting Chie f, Ge ria tric s Bra nc h Divisio n o f Ge ria tric s a nd Clinic a l Ge ro nto lo g y a t the Na tio na l I nstitute o f Ag ing e lda da hb @ nia .nih.g o v

  3. NIA Mission T o impro ve the he a lth a nd we ll-b e ing o f o lde r Ame ric a ns thro ug h re se a rc h, a nd spe c ific a lly, to : • Suppo rt a nd c o nduc t hig h-q ua lity re se a rc h o n a g ing pro c e sse s, a g e -re la te d dise a se s, a nd spe c ia l pro b le ms a nd ne e ds o f the a g e d • T ra in a nd de ve lo p hig hly skille d re se a rc h sc ie ntists fro m a ll po pula tio n g ro ups • De ve lo p a nd ma inta in sta te -o f-the -a rt re so urc e s to a c c e le ra te re se a rc h pro g re ss • Disse mina te info rma tio n a nd c o mmunic a te with the pub lic a nd inte re ste d g ro ups o n he a lth a nd re se a rc h a dva nc e s a nd o n ne w dire c tio ns fo r re se a rc h.

  4. NIA Organization Office of the Director Intramural Research Program Division of Division of Geriatrics & Division of Division of Behavioral & Clinical Aging Biology Neuroscience Social Research Gerontology Extramural Divisions

  5. Relevant funding opportunities • “Advanc ing the Sc ie nc e of Ge r iatr ic Palliative Car e ” o R01: http:/ / g ra nts.nih.g o v/ g ra nts/ g uide / pa -file s/ PA- 13-354.html R03: http:/ / g ra nts.nih.g o v/ g ra nts/ g uide / PA-file s/ PA- o 13-356.html R21: http:/ / g ra nts.nih.g o v/ g ra nts/ g uide / PA-file s/ PA- o 13-355.html • “Pain in Aging” o R01: http:/ / g ra nts.nih.g o v/ g ra nts/ g uide / PA-file s/ PA- 13-058.html R03: http:/ / g ra nts.nih.g o v/ g ra nts/ g uide / PA-file s/ PA- o 13-060.html o R21: http:/ / g ra nts.nih.g o v/ g ra nts/ g uide / PA-file s/ PA- 13-059.html

  6. Relevant NIA-Supported Research Centers • Alzhe ime r ’s Dise ase Re se ar c h Ce nte r s o http:/ / www.nia .nih.g o v/ a lzhe ime rs/ a lzhe ime rs- dise a se -re se a rc h-c e nte rs • Claude D. Pe ppe r Olde r Ame r ic ans Inde pe nde nc e Ce nte r s o https:/ / www.pe ppe rc e nte r.o rg / pub lic / ho me .c fm • Re sour c e Ce nte r s for Minor ity Aging Re se ar c h o http:/ / www.nia .nih.g o v/ re se a rc h/ db sr/ re so urc e - c e nte rs-mino rity-a g ing -re se a rc h-rc ma r

  7. Clinical Course of Advanced Dementia: Complications, Interventions, and Decision-Making Susan L. Mitchell MD, MPH

  8. Goals • Describe clinical course of advanced dementia • Present most common complications • Outline an approach to decision-making

  9. Epidemiology • Over 5 million Americans have Alzheimer’s disease, 16 million by 2050. • 5 th leading cause of death in US for persons > 65 years • Grossly underestimated on death certificates

  10. 2001 Location of Death 80 Hospital Nursing Home 70 Home 60 Other 50 % Deaths 40 30 20 10 0 Dementia Cancer Other conditions Mitchell SL et. al. JAGS 2005

  11. Advanced Dementia Global Deterioration Scale Stage 7 – Do not recognize family – Loss of all verbal abilities – Non-ambulatory – Incontinent * Reisberg B, J Psychiatry 1982

  12. Background • Palliative care sub-optimal across care settings: – Under-recognition as a terminal condition – Prognostication – Lack of high quality research – Under-utilization of hospice

  13. Cancer CHRONIC DISEASE

  14. Prognosis • Challenging • Guides decision making and hospice • Very limited empiric work • ADEPT study • ADEPT: AUROC = 0.68 • Hospice: AUROC = 0.55 • Receipt of palliative care should be based on goals of care * Mitchell SL, JAMA 2010

  15. Clinical Course • CASCADE study • Prospective study 323 NH resident with advanced dementia • 22 NHs in Boston

  16. Clinical Course • CASCADE study – Mortality: 55% over 18 months (40% over 12 months) – Expected complications • ~ 90% eating problems • ~50% recurrent infections/fever • Others rare (stroke, fracture, MI) – Burdensome symptoms • Increase toward death • Last 3 months: pain 25%; dyspnea 30% * Mitchell SL, NEJM 2009

  17. Decision-Making Proxy’s participated in 126 decisions Eating problem (29%) Pneumonia (19%) Febrile illness (6%) Pain Rx (18%) Dyspnea Rx (10%) Behavior Rx (10%) Seizure Rx (6%) Other (2%) Givens JL, JAGS 2009

  18. Decision-Making • Advance care planning is critical • Opportunity to discuss early – Prepare family for what to expect in advanced stages – Elicit wishes – Set the stage for future discussions

  19. Ethical Framework • Beneficence • Non-maleficence • Autonomy • Justice

  20. Steps to Operationalize Ethical Decision-Making 1. Clarify clinical situation 2. Determine primary goal of care 3. Present treatment options 4. Weigh options against perceived values

  21. Step 1: Clarify Clinical Situation • Eating problems – Very common in end-stage – Last activity of daily living to be lost

  22. Step 2: Goals of Care • Life prolongation • Maintain function • Comfort Gillick MR, JAMDA 2001

  23. Step 3: Present Options • Supportive care vs. long-term tube- feeding (PEG or J-tube)

  24. Ranking the Evidence • Randomized controlled trial 1st • None! • Cohort studies 2nd • Few • Selection bias • Case series (many) 3rd • Prognostic information • No control group

  25. Options: Hand-Feeding • Provide food and drink to the extent that is enjoyable • Sub-optimal nutrition in favor of comfort • Palliative care – Treatment not stopped

  26. Tube-feeding • Over 30% of nursing home residents with advanced dementia are tube-fed* • 68% of feeding-tube insertions occur during acute hospitalization** • Wide regional variation *Mitchell SL et al, JAMA;2004 **Kuo S et al, JAMDA;2009

  27. Options: Tube-Feeding • Purported benefits – Aspiration – Malnutrition – Survival – Comfort

  28. Arch Intern Med; 1997 1 Year Survival from Baseline by FT Status 1 .75 Survival JAGS; 2012 .5 .25 0 0 100 200 300 400 Days from Baseline No FT FT

  29. Tube-Feeding: Risks • Relatively safe procedure • Special considerations – Agitation – Hospital transfer for complications – Pressure ulcers: increased risk and poorer healing Teno et al, Arch Intern Med;2012

  30. Step 4: Weigh Options Options Advantages Disadvantages Hand- Tastes food Takes Time feeding Social Interaction Inconsistent Intake Focus on comfort Tube- Nutrition delivered No Clear Benefits feeding Complications

  31. Step 4: Weigh Options • Align with goal of care – Comfort Hand-Feeding – Prolong life ???

  32. Step 4: Weigh Options • Expert opinion and empiric data – tube-feeding has no demonstrable benefits in advanced dementia – tube-feeding should not be offered *Gillick MR, NEJM 2000 #Finucane T et al, JAMA 1999

  33. Pneumonia

  34. Step 1: Clarify Clinical Situation • Very common in end-stage dementia: ~ 50% last 90 days • High mortality • Discomfort:  symptoms* and treatment *van der Steen et al, JAGS 2002

  35. Step 2: Goals of Care • Life prolongation • Maintain function • Comfort Gillick MR, JAMDA 2001

  36. Step 3: Present Options

  37. Antimicrobial Exposure 45 % residents getting 40 35 antimicrobial 30 25 20 15 10 5 0 56-43 42-29 28-15 14-0 Days prior to death *D’Agata EMD, Mitchell SL Arch Int Med 2007

  38. Pneumonia: survival Survival after pneumonia episodes 1.00 0.75 0.50 0.25 0.00 0 200 400 600 analysis time No treatment Oral antimicrobials IM antimicrobials IV antimicrobials or hospitalization *Adjusted for age, gender, race, functional status, suspected aspiration, congestive heart failure, hospice referral, do-not-hospitalize order, and chest x-ray having been obtained. *Givens JL Arch Int Med 2010

  39. Pneumonia: Comfort 45 40 Mean SM_EOLD* 35 30 P trend = 0.01 25 20 15 10 5 0 None Oral IM IV or hospital Antibiotic treatment *Symptom Management at the End-of-Life in Dementia, range=0-45, higher score means more comfort

  40. Antimicrobial Resistance • Nursing home prevalence study (N=84) – 64% advanced dementia colonized – 3 times higher than other residents • Nursing home residents bring resistant bacteria into hospitals • Public health issue *Pop-Vicas A, J Am Geriatr Soc 2008\

  41. Step 4: Weigh Options Options Advantages Disadvantages No Greater Comfort Shorter Survival antibiotics/ palliation Antibiotics Prolong Survival Greater Discomfort Cost Antimicrobial Resistance

  42. Step 4: Weigh Options • Align with goal of care – Comfort Palliation only – Prolong life Antibiotics BUT… Oral may be adequate

  43. CASCADE: Hospital Transfers Admissions (N=74) % ER Visits (N=60) % Infections 59 Feeding Tube Cx 47 GI Bleed 8 Infection 27 Dyspnea 7 Fall 15 Fracture 5 Fracture 3 Heart Failure 3 Mental Status Change 2 Dehydration 3 Chest Pain 2 Feeding Tube Cx 3 IV insertion 2 Other 12 Jaundice 2

  44. Decision to Hospitalize • What is the goal of care? – Survival Comfort – 95% of proxies state comfort • Does hospitalization meet that goal?

Download Presentation
Download Policy: The content available on the website is offered to you 'AS IS' for your personal information and use only. It cannot be commercialized, licensed, or distributed on other websites without prior consent from the author. To download a presentation, simply click this link. If you encounter any difficulties during the download process, it's possible that the publisher has removed the file from their server.

Recommend


More recommend